Fifteen pharmaceutical and life sciences companies will work with the Bill and Melinda Gates Foundation to accelerate the development of vaccines, diagnostics, and treatments for COVID-19. The group will share proprietary compound libraries, along with safety and activity data, with the COVID-19 Therapeutics Accelerator, an effort the foundation launched last month with Wellcome and Mastercard. The 15 firms are also involved in other partnerships to develop COVID-19 therapies.
C&EN has made this story and all of its coverage of the coronavirus epidemic freely available during the outbreak to keep the public informed. To support our journalism, become a member of ACS or sign up for C&EN's weekly newsletter.